Navigation Links
FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
Date:5/21/2008

ine powder to provide topical, local analgesia to reduce the pain associated with peripheral IV insertions or blood draws. Zingo's rapid onset of action allows intravenous line placement or venipuncture to begin one to three minutes after administration. In clinical trials, the most common adverse events with Zingo were redness, red dots and swelling. For full Zingo prescribing information, go to http://www.anesiva.com/img/ZingoPackage.pdf

About Anesiva and its Diverse Pipeline of Pain Products

Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo(TM), for the reduction of pain associated with peripheral venous access procedures in children ages three to 18. The second product in Anesiva's pipeline, Adlea(TM), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, acute and chronic, moderate-to-severe pain. Anesiva is based in South San Francisco, CA. For more information about Anesiva's leadership in the development of products for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to http://www.anesiva.com.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. Forward- looking statements in
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
2. FDA Accepts Sucampos sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)
3. FDA Accepts Ranexa(R) sNDA and NDA for Filing
4. EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
5. Imaging Diagnostic Systems Accepts Resignations of Outside Directors
6. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
7. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
8. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
9. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
10. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
11. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... -- Current asthma medications, which work by suppressing ... the airways, can stop working over time. A ... Hospital and Harvard Medical School supports a surprising ... nerve endings in the lungs that help drive ... journal Neuron on June 25, the ...
(Date:6/25/2015)... (PRWEB) , ... June 25, 2015 , ... ... Framingham State University will enjoy (8) new chemistry laboratories, each exclusively using filtered ... week, Erlab’s team finished installing the (49) filtered fume hoods needed for their ...
(Date:6/25/2015)... , June 25, 2015  The Galien Awards Committee ... Genome Sciences and Medical Genetics at the University of ... Bono Humanum Award at the ninth annual Prix Galien ...   The Pro Bono Humanum Award recognizes ... the first woman recipient of the award.   ...
(Date:6/25/2015)... June 25, 2015 iAngels ... with Startup Nation,s leading angels and gain access to ... Darya Fuks as Portfolio Manager.  , ,Fuks, a ... lead iAngels, deal flow and due diligence activities for ... all iAngels portfolio companies. An investment banker with deep ...
Breaking Biology Technology:Targeting Nerve Endings To Curb Allergic Asthma 2Targeting Nerve Endings To Curb Allergic Asthma 3Targeting Nerve Endings To Curb Allergic Asthma 4Targeting Nerve Endings To Curb Allergic Asthma 5This Summer Erlab Completes the Largest Installation of Filtered Fume Hoods in the World 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 2The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree 3Former J.P. Morgan Vice President Darya Fuks Joins iAngels 2Former J.P. Morgan Vice President Darya Fuks Joins iAngels 3
... , , , , , ... for amplification. , For a quick overview you can browse ... Although all products will perform in a broad , array ... can be leveraged in your specific applications. This guide is designed to , ...
... , Here are some troubleshooting hints that we have gathered , regarding non-specific bands after PCR reactions: , ... , , , ... , <a , ... , , , ...
... , for routine amplification of up to 3 kb genomic ... , , , , , ... Kit contains 10 vials of 2x concentrated PCR reaction , mix ... detergent, dNTPs) plus water PCR grade (for dilution), sufficient for 100 , ...
Cached Biology Technology:Trouble-shooting: Non-specific bands 2Trouble-shooting: Non-specific bands 3Trouble-shooting: Non-specific bands 4Trouble-shooting: Non-specific bands 5Trouble-shooting: Non-specific bands 6PCR Master 2PCR Master 3
(Date:6/18/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market announces that its Wocket® smart wallet ... on the Mark", scheduled to air on WABC Radio (am770) ... th . The broadcast air- time for ... 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira will ...
(Date:6/17/2015)... Fla. , June 17, 2015  Crossmatch™, ... today announced that its U.are.U ® 4500 ... Togo,s Eateries, Inc., a ... sandwich chain, to increase security, improve accountability and ... readers enable instant, non-repudiable identity confirmation for employee ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue ... amount to at least 340 MSEK to that it will ... in market growth and orders received the revenue guidance for ... for 2015 will exceed 1,500 MSEK to an updated guidance ... Due to receipt of orders of touch fingerprint ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
... team led by scientists at the Sainsbury Laboratory in ... plant diseases across different plant families. This breakthrough ... resistance to economically important diseases. Food insecurity is driving ... food we grow, whilst at the same time reducing ...
... decades, scientists have been pursuing a potential new way ... as antimicrobial peptides (AMPs). Now, MIT scientists have recorded ... AMPs, most of which kill by poking holes in ... MIT Professor Angela Belcher modified an existing, extremely sensitive ...
... heart disease, less isn,t always more at least when ... increased risk of heart attack, stroke or death for patients ... low, according to Rhonda Cooper-DeHoff, Pharm.D., an associate professor of ... (Sunday, March 14) at the American College of Cardiology,s 59th ...
Cached Biology News:New defenses deployed against plant diseases 2New microscopy technique offers close-up, real-time view of cellular phenomena 2UF researcher urges caution in reducing blood pressure in patients with diabetes, coronary disease 2